WallStSmart

Covista Inc. (CVSA)vsStride Inc (LRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stride Inc generates 33% more annual revenue ($2.52B vs $1.89B). CVSA leads profitability with a 13.4% profit margin vs 12.7%. LRN appears more attractively valued with a PEG of 0.46. LRN earns a higher WallStSmart Score of 77/100 (B+).

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0

LRN

Strong Buy

77

out of 100

Grade: B+

Growth: 9.3Profit: 7.0Value: 10.0Quality: 9.0
Piotroski: 4/9Altman Z: 3.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$106.98

$9.75 premium

UndervaluedFair: $97.23Overvalued
LRNUndervalued (+71.8%)

Margin of Safety

+71.8%

Fair Value

$304.67

Current Price

$85.06

$219.61 discount

UndervaluedFair: $304.67Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
15.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

LRN6 strengths · Avg: 9.5/10
PEG RatioValuation
0.4610/10

Growing faster than its price suggests

Revenue GrowthGrowth
47.8%10/10

Revenue surging 47.8% year-over-year

EPS GrowthGrowth
108.3%10/10

Earnings expanding 108.3% YoY

Altman Z-ScoreHealth
3.9210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
22.3%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
12.7x8/10

Attractively priced relative to earnings

Areas to Watch

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

LRN0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bull Case : LRN

The strongest argument for LRN centers on PEG Ratio, Revenue Growth, EPS Growth. Revenue growth of 47.8% demonstrates continued momentum. PEG of 0.46 suggests the stock is reasonably priced for its growth.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Bear Case : LRN

No major red flags identified for LRN, but monitor valuation.

Key Dynamics to Monitor

CVSA profiles as a value stock while LRN is a growth play — different risk/reward profiles.

CVSA carries more volatility with a beta of 0.73 — expect wider price swings.

LRN is growing revenue faster at 47.8% — sustainability is the question.

LRN generates stronger free cash flow (106M), providing more financial flexibility.

Bottom Line

LRN scores higher overall (77/100 vs 67/100) and 47.8% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Stride Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Stride, Inc., a technology-based education company, provides its own and third-party online educational services, software systems and curricula to facilitate individualized learning for students primarily in kindergarten through grade 12 (K -12) in the United States and internationally. .

Visit Website →

Want to dig deeper into these stocks?